Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Immunological Investigations|September 29, 2012
Highlights on molecular mechanisms of MDSC-mediated immune suppression: paving the way for new working hypothesesSamantha Solito, Laura Pinton, Vera Damuzzo, et al.
Cancers|April 13, 2023
Progression-Free and Overall Survival of First-Line Treatments for Advanced Renal Cell Carcinoma: Indirect Comparison of Six Combination RegimensAndrea Ossato, Daniele Mengato, Marco Chiumente, et al.
Oncology Research|June 26, 2026
Progression-Free Survival with PARP Inhibitors According to Clinical Risk in Patients with Ovarian Cancer: An Indirect Comparison Using Reconstructed DataLorenzo Gasperoni, Luna Del Bono, Alberto Farolfi, et al.
Journal of Chemotherapy (Florence, Italy)|October 21, 2024
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient dataAndrea Ossato, Luna Del Bono, Lorenzo Gasperoni, et al.
Journal of Pharmacy Practice|December 28, 2017
Comorbidity, Polytherapy, and Drug Interactions in a Neurological Context: An Example of a Multidisciplinary Approach to Promote the Rational Use of DrugsGiulia Busa, Alessandro Burlina, Vera Damuzzo, et al.
Cancers|February 10, 2024
Efficacy of Immune Checkpoint Inhibitors vs. Tyrosine Kinase Inhibitors/Everolimus in Adjuvant Renal Cell Carcinoma: Indirect Comparison of Disease-Free SurvivalAndrea Ossato, Lorenzo Gasperoni, Luna Del Bono, et al.
Frontiers in Oncology|June 25, 2019
Analysis of Survival Curves: Statistical Methods Accounting for the Presence of Long-Term SurvivorsVera Damuzzo, Laura Agnoletto, Luca Leonardi, et al.
Annals of the New York Academy of Sciences|June 27, 2014
Myeloid-derived suppressor cell heterogeneity in human cancersSamantha Solito, Ilaria Marigo, Laura Pinton, et al.
Cancer Medicine|August 3, 2022
Immune checkpoint inhibitors as first line in advanced melanoma: Evaluating progression-free survival based on reconstructed individual patient dataAndrea Ossato, Vera Damuzzo, Paolo Baldo, et al.
Current Oncology (Toronto, Ont.)|January 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled TrialsAndrea Messori, Andrea Ossato, Lorenzo Gasperoni, et al.
Pageof 4